Trial reportThe oncologist2026
Effect of a patient decision aid on shared decision making in patients with differentiated thyroid cancer: a randomized controlled trial.
Trial report in The oncologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03905369 (Focus on Values to Stimulate Shared Decisions in Patients With Thyroid Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Focus on Values to Stimulate Shared Decisions in Patients With Thyroid Cancer: A Multifaceted COMmunication BOoster (COMBO)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
background: Over the last decades optimal treatment for patients with differentiated thyroid cancer (DTC) is debated. Two treatment decisions for patients who could benefit from more individualized approaches and shared decision making (SDM), are the extent of surgery decision in patients with low-risk DTC, and the decision to start or delay the treatment with Tyrosine Kinase Inhibitors (TKIs) in patients with advanced DTC. Our aim is to examine the effect of a Patient Decision Aid (PtDA) on observed SDM, while physicians were trained in SDM.
methodsIn this multicenter RCT (2020-2024), all physicians (n = 26) received a 5-hour SDM training. Patients (n = 86) with DTC were randomized to receive a PtDA or care as usual. The primary outcome was the observed SDM as rated by blinding observers with the observing patient involvement in decision making (OPTION5) scale from audio-recorded consultations. Secondary outcomes included well-being measures, information-related measures, and decision-related measures.
resultsMean OPTION5 scores were 52 (range 0-100) for the PtDA and 54 (range 0-100) for the usual care group. The PtDA did not improve observed SDM, nor the secondary outcomes. Results of the Beta testing (n = 33) showed that the PtDA was readable (n = 30) and helpful for decision making (n = 28). All patients recommended using the PtDA.
conclusionIn this RCT, with high baseline SDM quality provided by trained physicians, PtDAs did not further improve SDM quality. Nevertheless, since all patients recommended the PtDA, future studies should establish the potential benefit of PtDAs, particularly as SDM training is usually not provided.
trial registrationClinicalTrials.gov NCT03905369.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.